Search Within

Jason S Lewis

  1. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (12)
Groups
  1. Center for Hematologic Malignancies (27)
  2. Center for Pancreatic Cancer Research (27)
  3. GSK Faculty (27)
  4. Hematologic Malignancies Research (27)
  5. Radiochemistry and Imaging Sciences Service (27)
  6. Radiology, Department of (27)

More Groups

People
  1. Gabriela Chiosis (15)
  2. Tony Taldone (14)
  3. Mark Dunphy (13)
  4. Nagavarakishore Pillarsetty (12)
  5. Serge Lyashchenko (11)
  6. Steven Larson (11)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (3)
  4. 2016 (2)
  5. 2015 (5)
  6. 2014 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Journal of Nuclear Medicine (4)
  3. Cancer Research (3)
  4. Journal of Labelled Compounds and Radiopharmaceuticals (3)
  5. Science Translational Medicine (2)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (4)
  3. Society of Nuclear Medicine (4)
  4. Nature Publishing Group (3)
  5. Wiley Blackwell (3)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
    Journal Article

    Bolaender, A.; Zatorska, D.; He, H.; Joshi, S.; Sharma, S.; Digwal, C. S.; Patel, H. J.; Sun, W.; Imber, B. S.; Ochiana, S. O.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • CD38-targeted immuno-PET of multiple myeloma: From xenograft models to first-in-human imaging
    Journal Article

    Ulaner, G. A.; Sobol, N. B.; O'Donoghue, J. A.; Kirov, A. S.; Riedl, C. C.; Min, R.; Smith, E.; Carter, L. M.; Lyashchenko, S. K.; Lewis, J. S.; more...
    Radiology (2020)

    Fulltext@MSK | Save
  • Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Preclinical development and first-in-human imaging of 89Zr-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Burnazi, E.; Staton, K.; Weber, W.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71
    Journal Article

    Taldone, T.; Zatorska, D.; Ochiana, S. O.; Smith-Jones, P.; Koziorowski, J.; Dunphy, M. P.; Zanzonico, P.; Bolaender, A.; Lewis, J. S.; Larson, S. M.; more...
    Journal of Labelled Compounds and Radiopharmaceuticals (2016)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save